The efficacy of any pharmaceutical drug is intrinsically linked to the quality of its constituent components. For Montelukast Sodium, a medication widely used to manage asthma and allergic rhinitis, the Montelukast Sodium Intermediate plays a pivotal role. Understanding the detailed specifications of this intermediate, such as its purity, physical properties, and compliance with regulatory standards, is crucial for pharmaceutical manufacturers. NINGBO INNO PHARMCHEM CO.,LTD is committed to providing intermediates that meet the highest quality benchmarks, ensuring the integrity of the final therapeutic products.

The Montelukast Sodium Intermediate, bearing the CAS number 142569-70-8, is characterized by a series of precise metrics. Its high assay, typically ≥98.0% via HPLC, signifies a high degree of purity, which is essential for predictable chemical reactions in the synthesis process. Furthermore, its defined melting point range of 120-124ºC and a low loss on drying (≤1.0%) and water content (≤0.2%) are vital indicators of its stability and suitability for pharmaceutical applications. These parameters are meticulously controlled to meet the exacting demands of the Montelukast Sodium Chemical Synthesis.

The importance of these specifications extends beyond mere technical data; they directly impact the cost-effectiveness and success rate of drug manufacturing. A consistent and high-quality Montelukast Sodium Intermediate minimizes the risk of impurities carrying over into the final API, thus reducing the need for extensive purification steps. This focus on quality is a cornerstone of NINGBO INNO PHARMCHEM CO.,LTD's mission, providing pharmaceutical companies with reliable Montelukast Sodium Pharmaceutical Raw Material.

When sourcing pharmaceutical intermediates, identifying a trustworthy Montelukast Sodium Intermediate Supplier is paramount. Factors such as adherence to GMP, FDA, and MSDS standards, coupled with transparent documentation, build confidence in the product's quality. NINGBO INNO PHARMCHEM CO.,LTD prides itself on maintaining these high standards, ensuring that every batch of Montelukast Sodium Intermediate supplied meets the stringent requirements of the global pharmaceutical industry. Focusing on Montelukast Sodium Intermediate Purity is not just a preference; it is a necessity for producing safe and effective medicines.

In summary, the detailed specifications of the Montelukast Sodium Intermediate are critical for successful pharmaceutical manufacturing. NINGBO INNO PHARMCHEM CO.,LTD understands the importance of these parameters and is dedicated to supplying intermediates that uphold the highest levels of quality and consistency, contributing to the advancement of respiratory and allergy treatments.